Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 1
1999 1
2000 2
2001 6
2002 2
2005 3
2006 1
2007 2
2008 4
2009 2
2010 6
2011 6
2012 7
2013 10
2014 20
2015 15
2016 5
2017 3
2018 3
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24927273

90 results
Results by year
Filters applied: . Clear all
Page 1
Highly parallel characterization of IgG Fc binding interactions.
Boesch AW, Brown EP, Cheng HD, Ofori MO, Normandin E, Nigrovic PA, Alter G, Ackerman ME. Boesch AW, et al. MAbs. 2014 Jul-Aug;6(4):915-27. doi: 10.4161/mabs.28808. MAbs. 2014. PMID: 24927273 Free PMC article.
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR. Vafa O, et al. Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17. Methods. 2014. PMID: 23872058
Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
Lu J, Sun PD. Lu J, et al. Immunol Rev. 2015 Nov;268(1):192-200. doi: 10.1111/imr.12346. Immunol Rev. 2015. PMID: 26497521 Review.
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M, Schlothauer T, Dashivets T, Malik S, Avenal C, Bulau P, Rüger P, Reusch D. Thomann M, et al. PLoS One. 2015 Aug 12;10(8):e0134949. doi: 10.1371/journal.pone.0134949. eCollection 2015. PLoS One. 2015. PMID: 26266936 Free PMC article.
Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.
Jung ST, Reddy ST, Kang TH, Borrok MJ, Sandlie I, Tucker PW, Georgiou G. Jung ST, et al. Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):604-9. doi: 10.1073/pnas.0908590107. Epub 2009 Dec 18. Proc Natl Acad Sci U S A. 2010. PMID: 20080725 Free PMC article.
Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
Caaveiro JM, Kiyoshi M, Tsumoto K. Caaveiro JM, et al. Immunol Rev. 2015 Nov;268(1):201-21. doi: 10.1111/imr.12365. Immunol Rev. 2015. PMID: 26497522 Review.
Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
Hayes JM, Frostell A, Cosgrave EF, Struwe WB, Potter O, Davey GP, Karlsson R, Anneren C, Rudd PM. Hayes JM, et al. J Proteome Res. 2014 Dec 5;13(12):5471-85. doi: 10.1021/pr500414q. Epub 2014 Nov 11. J Proteome Res. 2014. PMID: 25345863
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity.
Bournazos S, Chow SK, Abboud N, Casadevall A, Ravetch JV. Bournazos S, et al. J Clin Invest. 2014 Feb;124(2):725-9. doi: 10.1172/JCI72676. Epub 2014 Jan 9. J Clin Invest. 2014. PMID: 24401277 Free PMC article.
Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1.
Nesspor TC, Raju TS, Chin CN, Vafa O, Brezski RJ. Nesspor TC, et al. J Mol Recognit. 2012 Mar;25(3):147-54. doi: 10.1002/jmr.2155. J Mol Recognit. 2012. PMID: 22407978
Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P. Borrok MJ, et al. MAbs. 2015;7(4):743-51. doi: 10.1080/19420862.2015.1047570. MAbs. 2015. PMID: 25970007 Free PMC article.
90 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page